Cardiovascular Systems Investor Relations Material
Latest events
Q1 2023
Cardiovascular Systems
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Cardiovascular Systems Inc
Access all reports
Cardiovascular Systems, Inc. develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products to treat various plaque types in above and below the knee, including calcified plaque; and peripheral support products under the Diamondback 360 brand name.
Latest articles
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
CSII
Country
🇺🇸 United States